0001104659-22-052533.txt : 20220428
0001104659-22-052533.hdr.sgml : 20220428
20220428182241
ACCESSION NUMBER: 0001104659-22-052533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220426
FILED AS OF DATE: 20220428
DATE AS OF CHANGE: 20220428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rajah Vignesh
CENTRAL INDEX KEY: 0001815042
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 22868796
MAIL ADDRESS:
STREET 1: HENRIKSHOJ 8
STREET 2: ROOM 4
CITY: VEDBAEK
STATE: G7
ZIP: DK-2950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
4
1
tm2213811-6_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-04-26
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001815042
Rajah Vignesh
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE SUITE 3350
NEW YORK
NY
10169
0
1
0
0
SVP & CMO
Employee Stock Option (right to buy)
9.51
2022-04-26
4
A
0
20000
0
A
2032-04-26
Common stock
20000
20000
D
Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
The stock option shall vest and become exercisable as to 50% of the shares subject to the options on April 26, 2023 and as to the remaining 50% of the shares subject to the options on April 26, 2024, subject to the continuing employment of the Reporting Person on each vesting date.
/s/ Vignesh Rajah
2022-04-28